Redwood Investments »

Halozyme Therapeutics shares owned by Redwood Investments

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Redwood Investments from 13F filings

Historical chart of Redwood Investments investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Redwood Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Redwood Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.4M 93k 36.96
2023-09-30 $13M 329k 38.20
2023-06-30 $16M 433k 36.07
2023-03-31 $16M 429k 38.19
2022-12-31 $25M 442k 56.90
2022-09-30 $18M 446k 39.54
2022-06-30 $24M 547k 44.00
2022-03-31 $15M 365k 39.88
2021-12-31 $15M 367k 40.21
2021-09-30 $25M 620k 40.68
2021-06-30 $25M 539k 45.41
2021-03-31 $23M 543k 41.69
2020-12-31 $27M 632k 42.71
2020-09-30 $16M 598k 26.28
2020-06-30 $12M 446k 26.81